Recommendable! Cancer is history (soon)!
"... The key was using extremely powerful ultrasound to produce negative pressure of more than 20 megapascals, delivered in short bursts measured in microseconds—but separated by relatively long gaps, between a millisecond and a full second long. These parameters created bubbles that quickly formed and collapsed, tearing apart nearby cells and turning the tissue into a kind of slurry, while avoiding heat buildup. The result was a form of incisionless surgery, a way to wipe out tumors without scalpels, radiation, or heat. ...
In 2023, HistoSonics’ Edison system received FDA approval for treatment of liver tumors.
In 2026, clinicians will conclude a pivotal kidney cancer study and apply for regulatory approval.
They’ll also launch a large-scale pivotal trial for pancreatic cancer ...
They’ll also launch a large-scale pivotal trial for pancreatic cancer ...
Over the past decade, research has confirmed or found other benefits of histotripsy. With precise calibration, fibrous tissue—such as blood vessels—can be spared from damage even in the target zone. And while other noninvasive techniques may leave scar tissue, the liquefied debris created by histotripsy is cleared away by the body’s natural processes. ...
Histotripsy generally seems to stimulate an immune response, helping the body attack cancer cells that weren’t targeted directly by ultrasound. The mechanical destruction of tumors likely leaves behind recognizable traces of cancer proteins that help the immune system learn to identify and destroy similar cells elsewhere in the body ...
Engineers are already testing a new guidance system that uses a form of X-rays rather than ultrasound imaging, which should expand use cases. The R&D team is also developing a feedback system that analyzes echoes from the therapeutic ultrasound to detect tissue destruction and integrates that information into the live display ..."
No comments:
Post a Comment